Blog
Filter blogs by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Pre-emptive vaccine research to improve EID response
This blog explores strategies for strengthening vaccine development so that the medical community is better prepared to respond to future epidemics.
-
Use of ddPCR and qPCR assays for PK and safety monitoring in Cell & Gene Therapy clinical trials
Immunotherapy technologies are rapidly advancing, as are the methods of ensuring their safety and reliability. ICON explores the tools used in CGT trials.
-
From clinician visits to data analysis: the challenges and solutions in COVID vaccine pharmacovigilance
Learn more about the challenges and solutions in assessing the long-term effects of Covid and Covid vaccines in this blog.
-
Mary O’Reilly reflects on International Women’s Day
In this blog, Mary O’Reilly reflects on the International Women’s Day panel and events held at ICON’s global headquarters in Dublin.
-
How data science is changing the face of healthcare
In this podcast, Michael Goedde shares his journey in technology and his role in building the digital platform for healthcare systems at ICON.
-
A positive step for diversity and inclusion in clinical trials – reflections on FDORA
Read this blog for updated recommendations and additional guidance on DCTs to ensure equitable access to cutting-edge therapeutics and clinical trials.
-
Rare Disease Day diversity and inclusion
This event aims to raise awareness about the diversity of individuals affected by rare diseases. Find out how virtual events can be made more accessible and inclusive.
-
-
My patient story - Claudia Egremont-Lee
ICON's Claudia Egremont-Lee shares her personal experience with breast cancer.
-
My patient story - Margaritte De Falco
ICON's Margaritte De Falco shares her personal experience with ovarian cancer.
-
The importance of developing rTPP to build biotech asset value
Discover how Biotechs can build value into their asset by developing a reimbursable Target Product Profile (rTPP).
-
The impact of real world evidence on drug marketing approval and reimbursement
Increasing use of real world data and real world evidence for market regulatory decisions can lead to a more holistic understanding of safety and potency factors for healthcare practices.
-
Redefining sourcing model terminology
This blog explores the new framework for defining CRO sourcing models and explains its importance.
-
Optimising biotech trial designs to stretch your cash runway
Read this blog to learn a few key considerations to help optimise and de-risk your trial design.
-
Crafting a competitive biotech funding pitch
Biotechs can hone their pitch with the guidelines provided in this blog and through early engagement opportunities with strategic partners.
-
Medical device classifications and applicable Food and Drug Administration regulations
Medical device manufacturers should understand how their product is viewed by regulatory bodies to proceed with the appropriate regulatory pathway to market.
-
Filling the gaps for rare and orphan diseases
Read the blog to learn more about the benefits and challenges of Rare Disease natural history studies.
-
Pharmacovigilance outsourcing: Tips for selecting a service provider
Selecting a vendor requires careful exploration and planning to ensure a successful relationship between sponsor and outsourcing partner.
-
MDR transition period and certification bottleneck
It is of paramount importance that companies with expiring certification begin the process to remain compliant under the new MDR. Read more about identified challenges and solutions.
-
Implementing surveillance measures to prioritise patient safety
Patient centricity is a top priority at ICON. We use the latest technologies to detect and manage potential risks posed by medicinal products in accordance with GVP.